Molecular Imaging for Brain Diseases
| Autor corporatiu: | |
|---|---|
| Altres autors: | |
| Sumari: | XIII, 210 p. 39 illus., 35 illus. in color. text |
| Idioma: | anglès |
| Publicat: |
New York, NY :
Springer US : Imprint: Humana,
2025.
|
| Edició: | 1st ed. 2025. |
| Col·lecció: | Neuromethods,
222 |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/978-1-0716-4494-2 |
| Format: | Electrònic Llibre |
Taula de continguts:
- Recent progress in NMDA glutamate receptor imaging
- Manipulation and imaging of plasticity of the glutamate synapse for brain diseases in living human
- Advanced Tau imaging in Alzheimer's disease and other types of dementia
- PET visualization of brain tau accumulations secondary to various CNS injuries: Chronic traumatic encephalopathy (CTE) and organophosphorus poisoning
- Amyloid PET imaging and quantification of amyloid deposition
- 18F-FDG PET for Neurodegenerative Diseases: Principles and Progress
- Opioid receptor and advanced nuclear imaging in epilepsy
- High-affinity state of dopamine D2/3 receptors in schizophrenia: A dual-radioligand approach
- Finding the Fire: Mapping Brain Temperature Elevations as a Surrogate of Focal Neuroinflammation
- Magnetic resonance spectroscopy and its application of mild traumatic brain injury
- Glutamate and proton MR Spectroscopy in Schizophrenia
- Artificial Intelligence for Molecular Brain Imaging.